Jari Häkkinen

Lund University — Sweden

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index3.1kcitations133works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(34), Breast Cancer Treatment Studies(21), Gene expression and cancer classification(20), Advanced Proteomics Techniques and Applications(18), Molecular Biology Techniques and Applications(12)

Publications133 total

Code associated with Kurochkin et al., 2025.
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
Code associated with Kurochkin et al., 2025.
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
Supplementary Figure 3 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 6 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Data from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Table 1 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 4 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 3 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 2 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Table 2 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 6 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 5 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Table 1 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Table 3 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 2 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 5 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Figure 1 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 1 from Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
2025Open Access
Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer
Cancer Research Communications·2025Open Access
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
2025· 1 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Johan Vallon‐Christersson(25), Åke Borg(21), Lao H. Saal(16), Anna Ehinger(15), Cecilia Hegardt(14), Lisa Rydén(14), Martin Malmberg(14), Johan Staaf(12), Niklas Loman(11), Christer Larsson(11), Anders Kvist(5), Christof Winter(5), Christian Brueffer(5), Pär‐Ola Bendahl(5), Markus Ringnér(4), Yilun Chen(4), Anthony M. George(4), Göran Jönsson(4), Fredrik Levander(4), Helena Olofsson(4)